ОСОБЛИВОСТІ МАМОГРАФІЧНОІ ЩІЛЬНОСТІ СИНХРОННОГО БІЛАТЕРАЛЬНОГО РАКУ МОЛОЧНОЇ ЗАЛОЗИ
Ключові слова:
синхронний двосторонній рак молочної залози, мамографічна щільність
Анотація
Нами встановлено, що ступінь мамографічної щільності у хворих на синхронний БРМЗ є вищим в порівнянні з здоровими пацієнтками і в меншій мірі в порівнянні з хворими на односторонній РМЗ. Найбільш поширеним ступенем - є другий ступінь мамографічної щільності у хворих на синхронний БРМЗ, і становить 60%.
Посилання
1. Mikael Hartman, Kamila Czene, Marie Reilly, Jan Adolfsson, Jonas Bergh, Hans-Olov Adami, Paul W. Dickman, Per Hall. Incidence and Prognosis of Synchronous and Metachronous Bilateral Breast CancerZ/Journal of Clinical Oncology’, Vol 25, No 27 (September 20), 2007: pp. 4210-4216.
2. F.Boyd, M.J.Yaffe. Mammographic density. Measurement of mammographic density.// Breast Cancer Research. - 2008; 10:pp. 209-11.
3. Edward A Sickles Wolfe mammographic parenchymal pattern and breast cancer risk.// AJR.- 2007, 188:pp.301- 303.
4. Boyd NF, Dite GS, Stone J, et al. Heritability of mammographic density, a risk factor for breast cancer N Engl J Med 2002;347:886-94.
5. Leon Speroff. The clinical implication of hormone- induced breast density. Menopausal med. 2005, 13-2:1-5.
6. Wolfe JN. Breast patterns as an index of risk for developing breast cancer Am J Roentgenol 1976; 126: 1130-9.
7. Wolfe JN. Risk for breast cancer development determ ined by mammographic parenchymal pattern. Cancer 1976;37:2486-92.
8. Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000:92:1081 — 7.
9. Valerie A McCormack, Isabel dos Santos Silva. Breast density and parenchymal mammographic as marker of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15:1159-69.
10. Carol J Fabian, Bruce F Kimi er Mammographic density: use in risk assessment and as a biomarker in prevention trails. J Nutr. 2006, 136:2705S-2708S.
11. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003 Feb 4:138:168-75.
12. Lisa J Martin, Norman F Boyd Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density’: hypotheses based on epidemiological evidence. Author information 2008.
13. Cavallaro U, Cristofori G. Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim. Biophys. Acta. 20011552: 39-45.
14. Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson PH. Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res 2003;5:P129 - 35.
15. Симпозиум в Сан-Антонио no лечению рака молочной железы. Lancet. Oncology’. 2009; 4(9): 10-11.
16. Sala Е, Solomon L, Warren R, et al. Size, node status and grade of breast tumors: association with mammographic parenchymal patterns. Eur Radiol 2000;10:157 - 61.
2. F.Boyd, M.J.Yaffe. Mammographic density. Measurement of mammographic density.// Breast Cancer Research. - 2008; 10:pp. 209-11.
3. Edward A Sickles Wolfe mammographic parenchymal pattern and breast cancer risk.// AJR.- 2007, 188:pp.301- 303.
4. Boyd NF, Dite GS, Stone J, et al. Heritability of mammographic density, a risk factor for breast cancer N Engl J Med 2002;347:886-94.
5. Leon Speroff. The clinical implication of hormone- induced breast density. Menopausal med. 2005, 13-2:1-5.
6. Wolfe JN. Breast patterns as an index of risk for developing breast cancer Am J Roentgenol 1976; 126: 1130-9.
7. Wolfe JN. Risk for breast cancer development determ ined by mammographic parenchymal pattern. Cancer 1976;37:2486-92.
8. Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000:92:1081 — 7.
9. Valerie A McCormack, Isabel dos Santos Silva. Breast density and parenchymal mammographic as marker of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15:1159-69.
10. Carol J Fabian, Bruce F Kimi er Mammographic density: use in risk assessment and as a biomarker in prevention trails. J Nutr. 2006, 136:2705S-2708S.
11. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003 Feb 4:138:168-75.
12. Lisa J Martin, Norman F Boyd Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density’: hypotheses based on epidemiological evidence. Author information 2008.
13. Cavallaro U, Cristofori G. Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim. Biophys. Acta. 20011552: 39-45.
14. Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson PH. Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res 2003;5:P129 - 35.
15. Симпозиум в Сан-Антонио no лечению рака молочной железы. Lancet. Oncology’. 2009; 4(9): 10-11.
16. Sala Е, Solomon L, Warren R, et al. Size, node status and grade of breast tumors: association with mammographic parenchymal patterns. Eur Radiol 2000;10:157 - 61.
Опубліковано
2010-03-29
Як цитувати
Чешук , В., Зотов , О., Енгел , О., Зайчук , В., Штефура , В., & Щепотін , І. (2010). ОСОБЛИВОСТІ МАМОГРАФІЧНОІ ЩІЛЬНОСТІ СИНХРОННОГО БІЛАТЕРАЛЬНОГО РАКУ МОЛОЧНОЇ ЗАЛОЗИ. Український науково-медичний молодіжний журнал, 1(1), 50-53. вилучено із http://mmj.nmuofficial.com/index.php/journal/article/view/279
Розділ
Медицина
